A Phase II Study of Weekly Nanoparticle Albumin-Bound Paclitaxel With or Without Trastuzumab in Metastatic Breast Cancer-Reference-Cited by-同舟云学术

A Phase II Study of Weekly Nanoparticle Albumin-Bound Paclitaxel With or Without Trastuzumab in Metastatic Breast Cancer

Published:2011-04 Issue:2 Volume:11 Page:121-128
ISSN:1526-8209
Container-title:Clinical Breast Cancer
language:en
Short-container-title:Clinical Breast Cancer

Author:

Mirtsching Barry,Cosgriff Thomas,Harker Graydon,Keaton Mark,Chidiac Tarek,Min Myo

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference47 articles.

1. Cancer Statistics, 2010;Jemal;CA Cancer J Clin,2010

2. Taxanes in breast cancer: an update;Conlin;Curr Oncol Rep,2007

3. Clinical Practice Guidelines in Oncology;Breast Cancer,2010

4. Chemotherapy for metastatic breast cancer;Mayer;Hematol Oncol Clin North Am,2007

5. Altekruse SF, Kosary CL, Krapcho M, et al (eds). SEER Cancer Statistics Review, 1975–2007. National Cancer Institute. Bethesda, MD. Available at: http://seer.cancer.gov/csr/1975_2007. Based on November 2009 SEER data submission, posted to the SEER web site, 2010.

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Three-Week Versus 4-Week Schedule of nab-Paclitaxel in Patients With Metastatic Breast Cancer: A Randomized Phase II Study;The Oncologist;2023-10-26

2. Nanoparticles in the diagnosis and treatment of cancer metastases: Current and future perspectives;Cancer Letters;2023-03

3. Phase 2 prospective open label study of neoadjuvant nab‐paclitaxel, trastuzumab, and pertuzumab in patients with HER2‐positive primary breast cancer;Cancer;2022-12-14

4. Pyrotinib-based treatments in HER2-positive breast cancer patients with brain metastases;Annals of Medicine;2022-11-04

5. Current trends in the use of human serum albumin for drug delivery in cancer;Expert Opinion on Drug Delivery;2022-10-17